BIANCA PREVIDI: Open Payments
NPI 1902060486 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$24,213 in 50 payments from 8 companies in 2025. Trend: 2023 $1,384 · 2024 $940 · 2025 $24,213
Speaker / faculty: $23,175Food & beverage: $953Travel & lodging: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $23,819 |
| Axsome Therapeutics, Inc. | 1 | $115 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $64 |
| Braeburn Inc. | 3 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Neurocrine BioSciences, Inc. | 1 | $38 |
| Janssen Pharmaceuticals, Inc | 1 | $31 |
Products named: VRAYLAR, Auvelity, CAPLYTA, BRIXADI, TRINTELLIX, REXULTI, INGREZZA, INVEGA SUSTENNA.
Industry payments across PA — which companies pay providers there.
